Log In
Print
BCIQ
Print
Print this Print this
 

CEP-32496

  Manage Alerts
Collapse Summary General Information
Company Ambit Biosciences Corp.
DescriptionSmall molecule BRAF kinase inhibitor
Molecular Target BRAF
Mechanism of ActionBRAF inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation

Partner

Teva Pharmaceutical Industries Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today